Ed P.

Role: Director, Medical Outcomes Science Liaison at Alnylam Pharmaceuticals
Location: Raleigh-Durham-Chapel Hill, NC, US
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

Experience

Director, Medical Outcomes Science Liaison
Alnylam Pharmaceuticals
Apr 2022 — Present

Education

University of Florida
Master's degree, Pharmaceutical Outcomes & Policy
2015 — 2018
University of the Sciences in Philadelphia
Certificate, Teaching Certificate Program
2012 — 2013
University of Pittsburgh
Doctor of Pharmacy (PharmD), Summa Cum Laude, Pharmacy
2006 — 2012

Skills

Clinical Pharmacy
Medical Communications
Data Presentation
Clinical Research
Microsoft Excel
Clinical Pharmacology
Systems Analysis
Pharmacy
Medical Writing
Pharmaceuticals
Presentation Preparation
Clinical Trials
Pharmacists
Oncology
Medication Therapy Management
Photoshop
Presentation Development
Technical Writing
Drug Information
Microsoft Word
Pharmaceutics
Pharmaceutical Industry
Excel
Managed Care
Pharmacoeconomics
Diabetes
Critical Thinking
Drug Product
Powerpoint
Verbal Communication
Healthcare
Word

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@alnylam.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Alnylam Pharmaceuticals

Biotechnology Research · 3K employees · Founded 2002 · Cambridge, Massachusetts, United States

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work. We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email m••••••@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (87••••••26), for Europe, +31•••••••61 Fraudulent Recruitment Activity Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

alnylam.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Director, Medical Outcomes Science Liaison

Education

University of Florida

University of the Sciences in Philadelphia

University of Pittsburgh

Skills

Find verified contacts for anyone on LinkedIn